MIDAS: AI Benchmarking for Skin Cancer

This research paper describes the creation and evaluation of the Multimodal Image Dataset for AI-Based Skin Cancer (MIDAS), a significant new resource for the development and testing of artificial intelligence models in dermatology. MIDAS is notable for being the largest publicly available dataset of biopsy-proven skin lesions that includes paired dermoscopic and clinical images, reflecting a…

Read More

Weekly Digest: Ambient AI Scribes in Clinical Documentation

Published: February 21, 2024Source: NEJM Catalyst Innovations in Care DeliveryAuthors: The Permanente Medical Group (TPMG) Overview The study by The Permanente Medical Group (TPMG) explores the implementation of ambient AI scribe technology to assist clinicians in documenting patient encounters. The pilot, conducted between August and December 2023, aimed to assess the tool’s impact on clinician…

Read More

Case Study: AI Startups in Early Warning Systems

Artificial Intelligence is increasingly being marketed as a solution for identifying early warning signs of clinical deterioration — such as sepsis, cardiac arrest, or respiratory failure. While the promise of anticipating critical illness is compelling, clinicians must approach these tools with caution, especially when the marketing outpaces the science. This page highlights what these AI…

Read More